Vaccine Clears Major Hurdle: Injections offer new tool against cervical cancers

By Nathan Seppa, 15:53 PM April 15, 2008

An experimental vaccine against the virus that causes most cancers of the cervix has passed—with flying colors—a test typically needed for regulatory approval.

The vaccine targets four strains of the sexually transmitted human papillomavirus (HPV), which infects about 20 million men and women in the United States. Last week in San Francisco at a meeting of the Infectious Diseases Society of America, researchers conducting a large trial in women reported that the vaccine prevented all cervical...

Source URL: